Delivery Order SPE2DR25D3201-SPE2DR26FT4MS
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (quantity: 30 count) under a firm fixed-price contract valued at $12,043.27. This non-competitive award, issued on December 9, 2025, with an ultimate completion date of December 10, 2025, represents a delivery order against AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The work will be performed at AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (quantity: 30 units) under a firm fixed-price contract valued at $49,291.72. The order, issued on December 2, 2025, with an ultimate completion date of December 3, 2025, represents a non-set-aside competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly...
- The Defense Logistics Agency awarded a delivery order valued at $4,483.25 to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count package) on November 3, 2025, with completion scheduled for November 4, 2025. This firm fixed-price delivery order represents a non-set-aside award and is performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award reflects AmerisourceBergen's role as a critical pharmaceutical distributor within the federal medical supply...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,378.10 for Arimidex 1 mg tablets (30-count packaging) with a completion date of November 14, 2025. This non-competitive, firm fixed-price delivery order was awarded on November 13, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor...
- The Defense Logistics Agency awarded a delivery order valued at $1,589.55 to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count package) on November 12, 2025, with completion expected by November 13, 2025. This non-competitive, firm fixed-price delivery order was issued under a larger Indefinite Delivery Contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical supplier for...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $4,726.80 to supply Arimidex 1 mg tablets in a 30-count package. The order, issued on December 5, 2025, with completion by December 8, 2025, represents a firm fixed-price delivery against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. This contract was awarded without set-aside provisions through open competition. The place of performance is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Arimidex 1 mg tablets in quantities of 30 units, with a ceiling value of $54,381.03. This firm fixed-price delivery order, with an ultimate completion date of December 9, 2025, represents a competitive award with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Arimidex 1 mg tablets (30-count units) with a ceiling value of $9,980.40. This firm fixed-price delivery order, which must be completed by December 12, 2025, represents a non-set-aside, competitively awarded contract under AmerisourceBergen's existing pharmaceutical supply agreement. The vendor, headquartered in Conshohocken, Pennsylvania, will perform work at its...
- The Defense Logistics Agency awarded a delivery order valued at $10,006.96 to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30 count). This firm fixed-price delivery order, awarded on October 24, 2025, with an ultimate completion date of October 27, 2025, represents a direct pharmaceutical procurement supporting federal medical supply requirements. The award was competitively awarded with no set-aside designation and is being performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,389.99 on December 8, 2025, for the supply of Arimidex 1 mg tablets in quantities of 30 units. This competitively awarded, firm fixed-price contract is scheduled for completion by December 9, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order carries no set-aside designation, reflecting the contractor's ability to compete in...
- SPE2DR25D3201Indefinite Delivery Contract
- SPE2DR25D3201-SPE2DR26FT4MSDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $34,247.33 to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count packaging) on December 8, 2025, with an ultimate completion date of December 9, 2025. This competitive award, utilizing firm fixed pricing with no set-aside designation, represents a direct fulfillment under the company's existing contract vehicle with DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA Medical Supply Chain. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract number SPE2DX), a comprehensive pharmaceutical prime vendor agreement valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a global pharmaceutical support vehicle enabling supply of a broad range of medications, vaccines, medical devices, and healthcare commodities to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. The award demonstrates the contractor's capability to meet federal procurement requirements through competitive selection and its continued role as a primary supplier within DLA's pharmaceutical procurement infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $34.2k | 12/7/25 |